- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 999-1013 of
1,041 results
1015 Exhibit: D Stevenson et al Efficacy and Safety of Cyclosporin A Ophthalmic E...
Document
IPR2017-00583, No. 1015 Exhibit - D Stevenson et al Efficacy and Safety of Cyclosporin A Ophthalmic Emulsion in the Treatment of Moderate to Severe Dry Eye Disease 107 OPHTHALMOL 967...
|
|
Cite Document
3001 Exhibit: Exhibit 3001
Document
IPR2017-00583, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Mar. 31, 2017)
|
|
Cite Document
1007 Exhibit: K Sall, et al, Two Multicenter, Randomized Studies of the Efficacy and...
Document
IPR2017-00583, No. 1007 Exhibit - K Sall, et al, Two Multicenter, Randomized Studies of the Efficacy and Safety of Cyclosporine Ophthalmic Emulsion in Moderate to Severe Dry Eye Disease, 10...
|
|
Cite Document
1018 Exhibit: A Kanpolat et al, Penetration of Cyclosporin A into the Rabbit Cornea...
Document
IPR2017-00583, No. 1018 Exhibit - A Kanpolat et al, Penetration of Cyclosporin A into the Rabbit Cornea and Aqueous Humor after Topical Drop and Collagen Shield Administration 20 CLAO J 11...
|
|
Cite Document
1019 Exhibit: A Vieira et al, Effect of ricinoleic acid in acute and subchronic experim...
Document
IPR2017-00583, No. 1019 Exhibit - A Vieira et al, Effect of ricinoleic acid in acute and subchronic experimental models of inflammation, 9 MED INFLAMM 223 2000 (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1013 Exhibit: Physicians¿¿¿ Desk Reference for Ophthalmic Medicines, 1999
Document
IPR2017-00583, No. 1013 Exhibit - Physicians¿¿¿ Desk Reference for Ophthalmic Medicines, 1999 (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1023 Exhibit: Complaint Allergan, Inc v Teva Pharmaceuticals USA, Inc, Teva Phar...
Document
IPR2017-00583, No. 1023 Exhibit - Complaint Allergan, Inc v Teva Pharmaceuticals USA, Inc, Teva Pharmaceutical Industries Ltd, Apotex, Inc, Apotex Corp, Akorn, Inc, Mylan Pharmaceuticals I...
|
|
Cite Document
1025 Exhibit: DECLARATION OF WALTER G CHAMBLISS, PHD
Document
IPR2017-00583, No. 1025 Exhibit - DECLARATION OF WALTER G CHAMBLISS, PHD (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1006 Exhibit: US Patent No 5,474,979 to Ding et al, filed May 17, 1994
Document
IPR2017-00583, No. 1006 Exhibit - US Patent No 5,474,979 to Ding et al, filed May 17, 1994 (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1024 Exhibit: Approved Drug Products with Therapeutic Equivalence Evaluations 3...
Document
IPR2017-00583, No. 1024 Exhibit - Approved Drug Products with Therapeutic Equivalence Evaluations 34th Ed 2014 Excerpts (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1017 Exhibit: E Goto et al Low Concentration Homogenized Castor Oil Eye Drops fo...
Document
IPR2017-00583, No. 1017 Exhibit - E Goto et al Low Concentration Homogenized Castor Oil Eye Drops for Noninflamed Obstructive Meibomian Gland Dysfunction 109 OPHTHALMOL 2030 2002...
|
|
Cite Document
1004 Exhibit: File history of US Patent No 8, 633,162 to Acheampong et al Part 3
Document
IPR2017-00583, No. 1004-3 Exhibit - File history of US Patent No 8, 633,162 to Acheampong et al Part 3 (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1002 Exhibit: Declaration of Dr Mansoor Amiji
Document
IPR2017-00583, No. 1002 Exhibit - Declaration of Dr Mansoor Amiji (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1003 Exhibit: Curriculum Vitae of Dr Mansoor Amiji
Document
IPR2017-00583, No. 1003 Exhibit - Curriculum Vitae of Dr Mansoor Amiji (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
1026 Exhibit: Curriculum Vitae of Dr Walter Chambliss
Document
IPR2017-00583, No. 1026 Exhibit - Curriculum Vitae of Dr Walter Chambliss (P.T.A.B. Jan. 6, 2017)
|
|
Cite Document
